MarketReportsOnline.com adds "The US Chronic Pain Market - Focus on Opioids: Trends & Opportunities (2014-2019)" report to its research store.
Dallas, TX -- (SBWIRE) -- 12/04/2014 -- The report titled "The US Chronic Pain Therapy Market: Trends & Opportunities (2014-2019)" provides an in-depth analysis of the United States chronic pain therapy market (including medication, surgeries and therapies) with detailed analysis of market sizing and growth and market share of the various drugs involved in the treatment of chronic pain. The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall chronic pain therapy market has also been forecasted for the period 2014-19, taking into consideration the previous growth patterns, the growth drivers and the current and future trends. Further, key players of the industry like Zogenix Inc., Egalet Corporation and NektarTheropeutics are profiled.
Complete report available at http://www.marketreportsonline.com/376611.html.
- Zogenix Inc.
- Egalet Corporation
Chronic pain, defined as pain that lasts longer than six months and about 100 million Americans suffer from chronic pain that could be mild or agonizing, episodic or continuous, merely inconvenient or totally incapacitating.
The US chronic pain therapy market is expected to experience slow pace of growth in the near future. The major opioids used for medication in chronic pain are Oxycodone, Hydrocodone, Fentanyl, Methadone, Morphine, Hydromorphone and Dihydrocodeine. Compared to other opioids, hydrocodone products, the most commonly prescribed opioid and the most commonly prescribed pharmaceutical products in the United States, are growing at a substantial pace in the overall chronic pain therapy market. In the oxycodone business domain, the expected launch of Egalet 002 in the second quarter of 2015 by the leading player Egalet will change the dynamics of this domain as currently Oxycotin dominates the oxycodone market.
Purchase a copy of this report at http://www.marketreportsonline.com/contacts/purchase.php?name=376611.
Major points from Table of Contents (http://www.marketreportsonline.com/376611-toc.html) are listed below:
List of Tables and Figures
Table 1: Types of Acute and Chronic pain
Table 2: WHO Guidelines for Pain Therapy
Figure 1: US Opioid Sales in Chronic Pain Therapy Market: 2009-2013 (in US$ billions)
Figure 2: US Opioid Sales in Chronic Pain Therapy Market - Forecast: 2014F-2019F (US$ B)
Figure 3: US Oxycodone Market: by value- 2009-2013 (in US$ billion)
Figure 4: Oxycodone Market: Share of Leading Players (2027)
Figure 5: US Oxycodone Market: By value – Forecast: 2014F-2019F (in US$ billion)
Figure 6: US Methadone Market: by Value- 2009-13 (in US$ million)
Figure 7: US Methadone Market: By value – Forecast: 2014F-2019F (in US$ million)
Figure 8: US Morphine Market: by value- 2009-13 (in US$ million)
Figure 9: US Morphine Market: By value – Forecast: 2014F-2019F (in US$ million)
Figure 10: US Long- Acting Morphine Market: 2014
Figure 11: US Hydromorphone Market: by Value- 2009-13 (in US$ million)
Figure 12: US Hydromorphone Market: By value – Forecast: 2014F-2019F (in US$ million)
Figure 13: US Hydrocodone Market: by Value- 2009-13 (in US$ billion)
Figure 14: US Hydrocodone Market: By value – Forecast: 2014F-19F (in US$ billion)
Figure 15: US Dihydrocodeine Market: by Value- 2009-13 (in US$ billion)
Figure 16: US Dihydrocodeine Market: By value – Forecast: 2014F-19F (in US$ billion)
Explore more reports on Pharmaceuticals Market at http://www.marketreportsonline.com/cat/pharmaceuticals-market-research.html.
MarketReportsOnline (http://www.marketreportsonline.com/) comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.
Mr. Ritesh Tiwari
TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252.
Tel: + 1 888 391 5441